вторник, 17 мая 2016 г.

Pfizer buying Anacor Pharmaceuticals in $5.2B deal46 minutes ago

Pfizer buying Anacor Pharmaceuticals in $5.2B deal46 minutes ago


Anacor's topical treatment for eczema, called crisaborole, is currently under review by the Food and Drug Administration. If approved, Pfizer said it believes peak year sales could reach or exceed $2 billion.



from Biotech News